Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.15 - $0.37 $51 - $128
-346 Reduced 0.08%
430,308 $68,000
Q1 2024

May 14, 2024

BUY
$0.19 - $0.3 $12,990 - $20,511
68,371 Added 18.87%
430,654 $116,000
Q2 2023

Aug 11, 2023

SELL
$0.35 - $0.72 $410 - $844
-1,173 Reduced 0.32%
362,283 $130,000
Q1 2023

May 15, 2023

BUY
$0.39 - $0.6 $6,580 - $10,123
16,872 Added 4.87%
363,456 $170,000
Q3 2022

Nov 14, 2022

BUY
$0.63 - $33.0 $17,808 - $932,811
28,267 Added 8.88%
346,584 $220,000
Q1 2022

May 13, 2022

SELL
$0.5 - $1.06 $6,252 - $13,255
-12,505 Reduced 3.78%
318,317 $256,000
Q3 2021

Nov 15, 2021

BUY
$0.67 - $1.51 $5,922 - $13,346
8,839 Added 2.75%
330,822 $430,000
Q1 2021

May 12, 2021

BUY
$0.96 - $1.74 $44,762 - $81,132
46,628 Added 16.93%
321,983 $338,000
Q4 2020

Feb 11, 2021

SELL
$0.76 - $1.47 $3,895 - $7,533
-5,125 Reduced 1.83%
275,355 $374,000
Q3 2020

Nov 16, 2020

SELL
$0.67 - $0.96 $834 - $1,196
-1,246 Reduced 0.44%
280,480 $215,000
Q2 2020

Aug 14, 2020

SELL
$0.52 - $0.92 $9,527 - $16,856
-18,322 Reduced 6.11%
281,726 $218,000
Q1 2020

May 14, 2020

BUY
$0.6 - $2.31 $36,978 - $142,367
61,631 Added 25.85%
300,048 $180,000
Q4 2019

Feb 14, 2020

BUY
$0.63 - $2.27 $1,007 - $3,629
1,599 Added 0.68%
238,417 $542,000
Q2 2019

Aug 13, 2019

BUY
$0.79 - $1.11 $43,333 - $60,885
54,852 Added 30.14%
236,818 $203,000
Q1 2019

May 13, 2019

SELL
$0.6 - $1.41 $405 - $951
-675 Reduced 0.37%
181,966 $198,000
Q4 2018

Feb 12, 2019

BUY
$0.53 - $1.11 $15,408 - $32,269
29,072 Added 18.93%
182,641 $109,000
Q2 2018

Aug 14, 2018

SELL
$0.42 - $0.74 $211,156 - $372,037
-502,753 Reduced 76.6%
153,569 $67,000
Q1 2018

May 09, 2018

BUY
$0.76 - $1.32 $13,501 - $23,449
17,765 Added 2.78%
656,322 $502,000
Q4 2017

Feb 14, 2018

SELL
$1.1 - $1.54 $8,688 - $12,164
-7,899 Reduced 1.22%
638,557 $741,000
Q3 2017

Nov 13, 2017

BUY
$1.19 - $1.43 $769,282 - $924,432
646,456
646,456 $854,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.